| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |